No Data
Idemitsu Kosan, Sumitomo Osaka Cement, etc. (additional) Rating
Upgraded - bullish code stock name brokerage firm previous changed after----------------------------------------------------------<9468>KADOKAWA Macquarie "Neutral" "Outperform" <5233> Taiheiyo Cement Daiwa "2" "1" target stock price change code stock name brokerage firm previous changed after----------------------------------------------
The Nikkei Average fell, with Tokyo Electric pushing down about 23 yen per share as one stock.
As of the market close 20 days ago, the number of rising and falling stocks in the Nikkei Average constituents was 68 stocks up, 156 stocks down, and 1 stock unchanged. The Nikkei Average fell for the first time in 7 days. It finished the morning session down 69.18 yen at 32,870.00 yen (volume approximately 0.6 billion 58.53 million shares). The Nikkei Average fell again, finishing the morning session down 172.08 yen (－0.45％) at 38,242.35 yen (volume approximately 0.8 billion 30 million shares). On the 19th, the US stock market was mixed. Dow inc was down 120.
Asahi Intecc, Mitsubishi Estate, etc. (additional) Rating
Target stock price change code stock name securities company previous change after --------------------------------------------------- <141A> Trial Mizuho 4,000 yen 4,200 yen <1925> Daiwa House SMBC Nikko 5,000 yen 5,400 yen <2802> Ajinomoto Mizuho 7,200 yen 7,250 yen <2875> Toyo Suisan SMBC Nikko 11,800 yen 12,600 yen <3110> Nitto Boseki Daiwa 6,000 yen 6,300 yen <3291>
Announcement of share buyback by SOMPOHD etc on November 19.
The stocks that announced the establishment of a self-share acquisition framework on November 19 (Tuesday) are as follows: <8630> SOMPO HD 72 million shares (7.4%) 155 billion yen (November 27, 24 - May 19, 25) <8766> Tokio Marine & Nichido Fire Insurance Co. 75 million shares (3.8%) 120 billion yen (November 20, 24 - May 15, 25) <8725> MS&AD Insurance Group Holdings Inc. 30 million shares (2.0%) 60 billion yen (November 20, 24 - March 24, 25) <6454> Max 0.6 million shares (1.3%) 2.4 billion yen (25/
Chordia---a biotech venture advancing the development of anticancer drugs that could become block inc.
Chordia Therapeutics <190A> is a biotech venture founded by drug discovery researchers who spun out from takeda pharmaceuticals sp adr <4502>, specializing in the development of low molecular weight anti-cancer drugs. The core business ranges from exploratory research to clinical research, and domestically, it conducts manufacturing and sales on its own through a partnership strategy, aiming for early monetization by licensing out overseas. It was listed on the Tokyo Stock Exchange Growth Market in June 2024.
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
○ Listed stocks for breaking through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange main board <1861> Kumagai Gumi 3575 3570 3365 <1979> Taiki 4970 4902.5 4675 <2207> Meito San 1919 1846.5 1909.5 <2305> Studio Alice 2081 2061.5 2045.5 <2471> Esupul 3443 422.5 299 <